EUVIMEDEUVIMED entdecken
Crossref

Long-term survival in patients with primary malignant brain tumors after postoperative home hydrogen inhalation: Three case reports

Ke-Cheng Xu, Xiao-Feng Kong, Wei Qian, Bing Liang, Ding-Gang Li, Nikolai N Korpan

World Journal of Clinical Cases · 16.07.2026 · 14 (20)

DOI: 10.12998/wjcc.121466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Clinical Cases, online erschienen am 16.07.2026. Verfasst von Ke-Cheng Xu und 5 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Primary malignant brain tumors [World Health Organization (WHO) Grades III and IV] have poor prognoses despite standard treatment. We report three cases of such tumors with markedly prolonged overall survival (OS) associated with long-term home hydrogen (H2) inhalation after conventional therapy. CASE SUMMARY Three patients: One with cerebellar medulloblastoma (MB), one with thalamic glioblastoma multiforme (GBM), one with an anaplastic oligoastrocytoma (AOA) evolving from a low-grade glioma, received standard surgery, radiotherapy and/or chemotherapy, followed by daily home inhalation of H2-oxygen (O2) gas mixture (66.6% H2 and 33.4% O2 at 3 L/minutes) for 4-10 hours/day. Clinical follow-up and serial brain magnetic resonance imaging (MRI) were performed. Case 1 (38-year-old female, cerebellar MB, subtotal approximately 70% resection) achieved OS of 52 months; postoperative MRI showed disappearance of the residual lesion. Case 2 (34-year-old female, thalamic GBM) achieved an OS of 38 months with no evidence of recurrence. Case 3 was a 56-year-old male with AOA WHO Grade III, 1p/19q non-codeleted, evolving from WHO Grade I-II astrocytoma, who achieved an OS of 93 months (80 months from the start of H2 inhalation). He maintained independent daily living, and MRI showed no obvious residual tumor. All patients regained normal daily activities and social functioning. The Karnofsky Performance Status score improves to 100 in Cases 1 and 2, and > 80 in Case 3. CONCLUSION These three cases of malignant brain tumors, with survival times greatly exceeding published norms, were associated with long-term home H2 inhalation after standard treatment. Given preclinical evidence of H2’s antioxidant, anti-inflammatory and antitumor properties, these findings warrant further investigation of H2 inhalation as a rehabilitation-adjunct therapy in patients with malignant brain tumors.

Zitieren

APA

Xu, K., Kong, X., Qian, W., Liang, B., Li, D., & Korpan, N. N. (2026). Long-term survival in patients with primary malignant brain tumors after postoperative home hydrogen inhalation: Three case reports. World Journal of Clinical Cases, 14(20). https://doi.org/10.12998/wjcc.121466

Vancouver

Xu K, Kong X, Qian W, Liang B, Li D, Korpan NN. Long-term survival in patients with primary malignant brain tumors after postoperative home hydrogen inhalation: Three case reports. World Journal of Clinical Cases. 2026;14(20). doi:10.12998/wjcc.121466

BibTeX
@article{Xu2026,
  author = {Xu, Ke-Cheng and Kong, Xiao-Feng and Qian, Wei and Liang, Bing and Li, Ding-Gang and Korpan, Nikolai N},
  title = {Long-term survival in patients with primary malignant brain tumors after postoperative home hydrogen inhalation: Three case reports},
  journal = {World Journal of Clinical Cases},
  year = {2026},
  volume = {14},
  number = {20},
  doi = {10.12998/wjcc.121466}
}
Kostenlos starten →